Nextcure to present at 23rd annual needham virtual healthcare conference

Beltsville, md., april 02, 2024 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 23rd annual needham virtual healthcare conference on thursday, april 11th, at 12:45 pm et.
NXTC Ratings Summary
NXTC Quant Ranking